Studies of the 48 bp repeat polymorphism of the DRD4 gene in impulsive, compulsive, addictive behaviors: Tourette syndrome, ADHD, pathological gambling, and substance abuse

American Journal of Medical Genetics - Neuropsychiatric Genetics

Volumn 88, Issue 4, 1999, Pages 358-368

  Comings, David E ^a   Gonzalez, Nancy ^a   Wu, Shijuan ^a   Gade, Radhika ^a   Muhleman, Donn ^a   Saucier, Gerard ^b   Johnson, Patrick ^c   Verde, Ray ^c   Rosenthal, Richard J ^d   Lesieur, Henry R ^e   Rugle, Loreen J ^f   Miller, Warren B ^g   MacMurray, James P ^h  

^a CITY OF HOPE NATIONAL MEDICAL CENTER   (United States)

^b CALIFORNIA STATE UNIVERSITY   (United States)

^c Jerry L Pettis VA Hospital   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e Institute for Problem Gambling   (United States)

^f Trimeridian Inc   (United States)

^g Transnational Family Research Institute   (United States)

^h LOMA LINDA UNIVERSITY   (United States)

Author keywords

Addictions; Dopamine receptors; Heterosis

Indexed keywords

ADDICTION; ADULT; AGED; ALLELE; ARTICLE; ATTENTION DEFICIT DISORDER; COMPULSION; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC POLYMORPHISM; GENOTYPE; GILLES DE LA TOURETTE SYNDROME; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; IMPULSIVENESS; MAJOR CLINICAL STUDY; MALE; PATHOLOGICAL GAMBLING; PRIORITY JOURNAL; STATISTICAL ANALYSIS; SUBSTANCE ABUSE;

ALLELES; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; CASE-CONTROL STUDIES; GAMBLING; GENOTYPE; HUMANS; HYBRID VIGOR; MULTIVARIATE ANALYSIS; PHENOTYPE; POLYMORPHISM, GENETIC; RECEPTORS, DOPAMINE D2; RECEPTORS, DOPAMINE D4; SUBSTANCE-RELATED DISORDERS; TANDEM REPEAT SEQUENCES; TOURETTE SYNDROME;

EID: 0033588059     PISSN: 15524841     EISSN: 1552485X     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8628(19990820)88:4<358::AID-AJMG13>3.0.CO;2-G     Document Type: Article

References (27)

1. Adamson MD, Kennedy J, Petronis A, Dean M, Virkkunn M, Linnoila M and Goldman D. 1995. DRD4 dopamine receptor genotype and CSF monoamine metabolites in Finnish alcoholics and controls. Am J Med Gen (Neuropsych Genet) 60:199-205.
2. Barr CL, Kennedy JL, Lichter JB, Vantol HHM, Wetterberg L, Livak KJ, Kidd KK. 1994. Alleles at the dopamine D-4 receptor locus do not contribute to the genetic susceptibility to schizophrenia in a large Swedish kindred. Am J Med Genet 48:218-222.
3. Barr CL, Wigg KG, Zovko E, Sandor P, Tsui L-C. 1996. No evidence for a major gene effect of the dopamine D4 receptor gene in the susceptibility to Gilles de la Tourette syndrome in five Canadian families. Am J Med Gen (Neuropsych Genet) 67:301-305.
4. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. 1996. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nature Genet 12:81-84.
5. Blum K, Wood RC, Sheridan PJ, Chen T, Comings DE. 1995. Doparaine D2 receptor gene variants: association and linkage studies in impulsive, addictive, and compulsive disorders. Pharmacogenetics 5:121-141.
6. Blum K, Cull JG, Braverman ER, Comings DE. 1996. Reward deficiency syndrome. Am Sci 84:132-145.
7. Budowle B, Chakiaborty R, Giusti AM, Eisenberg AJ, Allen PC. 1991. Analysis of the VNTR locus D1S80 by the PCR following by high resolution PAGE. Am J Hum Genet 48:137-144.
8. Chang FM, Ko HC, Lu RB, Pakstis AJ, Kidd KK. 1997. The dopamine D4 receptor gene (DRD4) is not associated with alcoholism in three Taiwanese populations: six polymorphisms tested separately and as haplotypes. Biol Psychiatry 41:394-405.
9. Cloninger CR, Svrakic DM, Przybeck TR. 1993. A psychobiological model of temperament and character. Arch Gen Psychiatry 50:975-990.
10. Comings DE, Comings EG, Muhleman D, Dietz G, Shahbahrami B, Tast D, Knell E, Kocsis P, Baumgarten R, Kovacs BW, Levy DL, Smith M, Kane JM, Lieberman JA, Klein DN, MacMurray J, Tosk J, Sverd J, Gysin R, Flanagan S. 1991. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. J Am Med Assn 266:1793-1800.
11. Comings DE, Muhleman D, Dietz G, Dino M, Legro R, Gade R. 1993a. Association between Tourette's syndrome and homozygosity at the dopamine-D3 receptor gene. Lancet 341:906.
12. Comings DE, Muhleman D, Dietz G, Dino M, Legro R. and Gade R. 1993b. Tourette's syndrome and homozygosity for the dopamine D3 receptor gene-reply. Lancet 341:1483-1484.
13. Comings DE, Muhleman D, Ahn C, Gysin R, Flanagan SD. 1994. The dopamine D2 receptor gene: a genetic risk factor in substance abuse. Drug Alcohol Dependence 34:175-180.
14. Comings DE. 1995a. The role of genetic factors in conduct disorder based on studies of Tourette syndrome and ADHD probands and their relatives. J Dev Behav Pediatr 16:142-157.
15. Comings DE. 1995b. Tourette syndrome: a hereditary neuropsychiatric spectrum disorder. Ann Clin Psychiatry 6:235-247.
16. Comings DE, Muhleman D, Gade R, Chiu C, Wu H, Dietz G, Winn-Dean E, Ferry L, Rosenthal RJ, Lesieur HR, Rugle L, Sverd J, Johnson P, MacMurray JP. 1996a. Exon and intron mutations in the human tryptophan 2,3-dioxygenase gene and their potential association with Tourette syndrome, substance abuse, and other psychiatric disorders. Pharmacogenetics 6:307-318.
17. Comings DE, Rosenthal RJ, Lesieur HR, Rugle L, Muhleman D, Chiu C, Dietz G, Gade R. 1996b. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 6:223-234.
18. Comings DE, Wu H, Chiu C, Ring RH, Dietz G and Muhleman D. 1996c. Polygenic inheritance of Tourette syndrome, stuttering, ADHD, conduct and oppositional defiant disorder: the additive and subtractive effect of the three dopaminergic genes - DRD2, D_H and DAT1. Am J Med Gen (Neuropsych Genet) 67:264-288.
19. Comings DE, Gade R, Wu S, Chiu C, Dietz G, Muhleman D, Saucier G, Ferry L, Burchete R, Johnson P, Verde R, MacMurray JP. 1997a. Studies of the potential role of the dopamine D1 receptor gene in addictive behaviors. Mol Psychiatry 2:44-56.
20. Comings DE, MacMurray JM. 1997a. Molelcular heterosis: Implications for psychiatric genetics. Am J Med Gen (Neuropsych Genet) 74:656.
21. Comings DE, MacMurray JM. 1997b. Molecular heterosis: Implications for complex inheritance. Am J Hum Genet 61:A196.
22. Comings DE, Muhleman D, Gade R, Johnson P, Verde R, Saucier G, MacMurray J. 1997b. Cannabinoid receptor gene (CNR1): association with IV drug use. Mol Psychiatry 2:161-168.
23. Comings DE. 1998a. Polygenic inheritance and micro/minisatellites. Mol Psychiatry 3:21-31.
24. Comings DE. 1998b. Molecular heterosis as the explanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor density. Mol Psychiatry (in press)
25. Comings DE. 1998c. Why Different Rules are Required for Polygenic Inheritance: Lessons from Studies of the DRD2 Gene. Alcohol 16:61-70.
26. Costa PTJ, McCrae RR. 1996. The revised NEO personality inventory (NEO-PI-R). New York: Plenum.
27. de Castro IP, Torres P, Fernandez-Piqueras J, Saiz-Ruiz J, Llinares C. 1994. No assciation between dopamine D4 receptor polymorphism and manic depressive illness. J Med Genet 31:897-898.